Ginsberg Gary, Rice Deborah
Connecticut Department of Public Health, Hartford, Connecticut, USA.
Environ Health Perspect. 2005 Sep;113(9):1117-9. doi: 10.1289/ehp.8254.
Human exposure to perchlorate is commonplace because it is a contaminant of drinking water, certain foods, and breast milk. The U.S. Environmental Protection Agency (EPA) conducted a perchlorate risk assessment in 2002 that yielded a reference dose (RfD) based on both the animal and human toxicology data. This assessment has been superceded by a recent National Academy of Science (NAS) review that derived a perchlorate RfD that is 20-fold greater (less stringent) than that derived by the U.S. EPA in 2002. The NAS-derived RfD was put on the U.S. EPA's Integrated Risk Information System (IRIS) database very quickly and with no further public review. In this commentary we raise concerns about the NAS approach to RfD development in three areas of toxicity assessment: the dose that the NAS described as a no observable adverse-effect level is actually associated with perchlorate-induced effects; consideration of uncertainties was insufficient; and the NAS considered the inhibition of iodine uptake to be a nonadverse effect. We conclude that risk assessors should carefully evaluate whether the IRIS RfD is the most appropriate value for assessing perchlorate risk.
人类接触高氯酸盐的情况很常见,因为它是饮用水、某些食物和母乳中的污染物。美国环境保护局(EPA)在2002年进行了一项高氯酸盐风险评估,根据动物和人体毒理学数据得出了参考剂量(RfD)。最近美国国家科学院(NAS)的一项审查取代了该评估,该审查得出的高氯酸盐RfD比美国环境保护局2002年得出的RfD高20倍(更宽松)。NAS得出的RfD很快就被放入了美国环境保护局的综合风险信息系统(IRIS)数据库,且没有进一步的公众审查。在这篇评论中,我们在毒性评估的三个方面对NAS制定RfD的方法提出了担忧:NAS描述为无明显不良效应水平的剂量实际上与高氯酸盐引起的效应有关;对不确定性的考虑不足;NAS认为碘摄取的抑制是一种非不良效应。我们得出结论,风险评估者应仔细评估IRIS RfD是否是评估高氯酸盐风险的最合适值。